Acurex Biosciences
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$2.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Acurex Biosciences operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Grant round in May 2026.
Acurex Biosciences is a biotechnology company that develops small-molecule medicines for the treatment of neurodegenerative diseases and movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acurex Biosciences Comparables
Compare Acurex Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arviat Pharmaceuticals, Inc. | 86% | |
| Praxis Precision Medicines, Inc. | 81% | |
| Vincere Biosciences | 80% |
For institutional investors. Book with your work email.
Acurex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Series A | May 27, 2026 | ||||
| Grant | Aug 7, 2024 | ||||
| Grant | Apr 27, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
Grant | Aug 31, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Acurex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aligning Science Across Parkinson's (ASAP) | Grant |
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant, Seed |
| The Silverstein Foundation for Parkinson's with GBA | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased by 48% MoM.
- May 27, 2026
Completed a Series A funding round.
For institutional investors. Book with your work email.
Acurex Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Acurex Biosciences's valuation, stock price, and market status.
Is Acurex Biosciences a public or private company?
Acurex Biosciences is a private company.
What is the current stock price of Acurex Biosciences?
Acurex Biosciences is a private company, so its shares have no public market price. Caplight tracks Acurex Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acurex Biosciences worth (valuation)?
Valuation information for Acurex Biosciences is not publicly available.
Can I buy Acurex Biosciences stock?
Acurex Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acurex Biosciences's last funding round?
Acurex Biosciences's most recent funding round was Grant on May 27, 2026.
Who are the main investors in Acurex Biosciences?
Key investors in Acurex Biosciences include Aligning Science Across Parkinson's (ASAP), NIH RADx, The Michael J. Fox Foundation for Parkinson's Research, The Silverstein Foundation for Parkinson's with GBA.
Will Acurex Biosciences IPO soon?
No public IPO plans have been announced for Acurex Biosciences.
How can I track Acurex Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Acurex Biosciences's shares on secondary markets.